Neil F. McFarlane insider trades

Open-market stock purchases and sales by Neil F. McFarlane, President and CEO at Zevra Therapeutics, Inc, from SEC Form 4 filings since Aug 15, 2016.

Recent trades

DateStockTradeValue
Oct 12, 2026ZVRA Zevra Therapeutics, IncSold$225K
Oct 10, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Oct 10, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Feb 9, 2026ZVRA Zevra Therapeutics, IncSold$125K
Feb 7, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Feb 2, 2026ZVRA Zevra Therapeutics, IncSold$853K
Jan 31, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—

Companies traded

  • ZVRA Zevra Therapeutics, Inc: 6 sales, last Oct 12, 2026
  • COLL Collegium Pharmaceutical, Inc: other filings, last May 16, 2024
  • ADMS Adamas Pharmaceuticals Inc: other filings, last Nov 24, 2021
  • RTRX Retrophin, Inc: 7 sales, last May 16, 2019

Get free alerts when Neil F. McFarlane files a new trade →